23149447|t|Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Abeta APP mutation.
23149447|a|Pathogenic amyloid-beta peptide precursor (APP) mutations clustered around position 693 of APP-position 22 of the Abeta sequence--are commonly associated with congophilic amyloid angiopathy (CAA) and intracerebral hemorrhages. In contrast, the Osaka (E693Delta) intra-Abeta APP mutation shows a recessive pattern of inheritance that leads to AD-like dementia despite low brain amyloid on in vivo positron emission tomography imaging. Here, we investigated the effects of the Osaka APP mutation on Abeta accumulation and deposition in vivo using a newly generated APP transgenic mouse model (E22DeltaAbeta) expressing the Osaka mutation together with the Swedish (K670N/M671L) double mutation. E22DeltaAbeta mice exhibited reduced alpha-processing of APP and early accumulation of intraneuronal fibrillar Abeta oligomers associated with cognitive deficits. In line with our in vitro findings that recombinant E22Delta-mutated Abeta peptides form amyloid fibrils, aged E22DeltaAbeta mice showed extracellular CAA deposits in leptomeningeal cerebellar and cortical vessels. In vitro results from thioflavin T aggregation assays with recombinant Abeta peptides revealed a yet unknown antiamyloidogenic property of the E693Delta mutation in the heterozygous state and an inhibitory effect of E22Delta Abeta42 on E22Delta Abeta40 fibrillogenesis. Moreover, E22Delta Abeta42 showed a unique aggregation kinetics lacking exponential fibril growth and poor seeding effects on wild-type Abeta aggregation. These results provide a possible explanation for the recessive trait of inheritance of the Osaka APP mutation and the apparent lack of amyloid deposition in E693Delta mutation carriers.
23149447	65	95	congophilic amyloid angiopathy	Disease	MESH:D016657
23149447	99	103	mice	Species	10090
23149447	131	136	Abeta	Gene	11820
23149447	265	270	Abeta	Gene	11820
23149447	310	340	congophilic amyloid angiopathy	Disease	MESH:D016657
23149447	342	345	CAA	Disease	MESH:D016657
23149447	351	376	intracerebral hemorrhages	Disease	MESH:D002543
23149447	419	424	Abeta	Gene	11820
23149447	493	509	AD-like dementia	Disease	MESH:D000544
23149447	528	535	amyloid	Disease	MESH:C000718787
23149447	648	653	Abeta	Gene	11820
23149447	729	734	mouse	Species	10090
23149447	814	819	K670N	ProteinMutation	tmVar:p|SUB|K|670|N;HGVS:p.K670N;VariantGroup:1;OriginalGene:11820;CorrespondingGene:351;RS#:371425292;CorrespondingSpecies:10090;CA#:319103474
23149447	820	825	M671L	ProteinMutation	tmVar:p|SUB|M|671|L;HGVS:p.M671L;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:572842823;CorrespondingSpecies:10090;CA#:319103456
23149447	858	862	mice	Species	10090
23149447	955	960	Abeta	Gene	11820
23149447	987	1005	cognitive deficits	Disease	MESH:D003072
23149447	1076	1081	Abeta	Gene	11820
23149447	1096	1103	amyloid	Disease	MESH:C000718787
23149447	1132	1136	mice	Species	10090
23149447	1158	1161	CAA	Disease	MESH:D016657
23149447	1244	1256	thioflavin T	Chemical	MESH:C009462
23149447	1293	1298	Abeta	Gene	11820
23149447	1628	1633	Abeta	Gene	11820
23149447	1782	1800	amyloid deposition	Disease	MESH:D058225
23149447	Association	RS#:371425292;HGVS:p.K670N;CorrespondingGene:351	RS#:572842823;HGVS:p.M671L;CorrespondingGene:351
23149447	Association	MESH:D016657	RS#:371425292;HGVS:p.K670N;CorrespondingGene:351
23149447	Association	MESH:D000544	11820
23149447	Association	MESH:D016657	RS#:572842823;HGVS:p.M671L;CorrespondingGene:351
23149447	Association	MESH:D016657	11820
23149447	Association	MESH:D003072	11820
23149447	Association	MESH:C000718787	11820
23149447	Association	MESH:D002543	11820
23149447	Association	MESH:D016657	351

